The analysis revealed that the N-terminus at TPR1 (peptide pool 1) and the region between DP1 and TPR2A (peptide pools 8–10) were preferably recognised by the plasma derived from Parkinson’s disease patients with high autoantibody levels against the STP1 protein (Figure 3A). The gene discussed is TTC1; the disease is Parkinson disease.